Global Influenza Vaccination Market Research Report 2024(Status and Outlook)
Report Overview:
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
The Global Influenza Vaccination Market Size was estimated at USD 3685.79 million in 2023 and is projected to reach USD 4883.13 million by 2029, exhibiting a CAGR of 4.80% during the forecast period.
This report provides a deep insight into the global Influenza Vaccination market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Vaccination Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Vaccination market in any manner.
Global Influenza Vaccination Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
Market Segmentation (by Type)
Egg Based
Cell Culture
Recombinant
Market Segmentation (by Application)
Hospitals
Research Organizations
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Vaccination Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
The Global Influenza Vaccination Market Size was estimated at USD 3685.79 million in 2023 and is projected to reach USD 4883.13 million by 2029, exhibiting a CAGR of 4.80% during the forecast period.
This report provides a deep insight into the global Influenza Vaccination market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Vaccination Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Vaccination market in any manner.
Global Influenza Vaccination Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
Market Segmentation (by Type)
Egg Based
Cell Culture
Recombinant
Market Segmentation (by Application)
Hospitals
Research Organizations
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Influenza Vaccination Market
- Overview of the regional outlook of the Influenza Vaccination Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Vaccination Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Influenza Vaccination
1.2 Key Market Segments
1.2.1 Influenza Vaccination Segment by Type
1.2.2 Influenza Vaccination Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA VACCINATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Vaccination Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Influenza Vaccination Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA VACCINATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Influenza Vaccination Sales by Manufacturers (2019-2024)
3.2 Global Influenza Vaccination Revenue Market Share by Manufacturers (2019-2024)
3.3 Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Vaccination Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Influenza Vaccination Sales Sites, Area Served, Product Type
3.6 Influenza Vaccination Market Competitive Situation and Trends
3.6.1 Influenza Vaccination Market Concentration Rate
3.6.2 Global 5 and 10 Largest Influenza Vaccination Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFLUENZA VACCINATION INDUSTRY CHAIN ANALYSIS
4.1 Influenza Vaccination Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA VACCINATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFLUENZA VACCINATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Vaccination Sales Market Share by Type (2019-2024)
6.3 Global Influenza Vaccination Market Size Market Share by Type (2019-2024)
6.4 Global Influenza Vaccination Price by Type (2019-2024)
7 INFLUENZA VACCINATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Vaccination Market Sales by Application (2019-2024)
7.3 Global Influenza Vaccination Market Size (M USD) by Application (2019-2024)
7.4 Global Influenza Vaccination Sales Growth Rate by Application (2019-2024)
8 INFLUENZA VACCINATION MARKET SEGMENTATION BY REGION
8.1 Global Influenza Vaccination Sales by Region
8.1.1 Global Influenza Vaccination Sales by Region
8.1.2 Global Influenza Vaccination Sales Market Share by Region
8.2 North America
8.2.1 North America Influenza Vaccination Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Influenza Vaccination Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Influenza Vaccination Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Influenza Vaccination Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Influenza Vaccination Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott (U.S.)
9.1.1 Abbott (U.S.) Influenza Vaccination Basic Information
9.1.2 Abbott (U.S.) Influenza Vaccination Product Overview
9.1.3 Abbott (U.S.) Influenza Vaccination Product Market Performance
9.1.4 Abbott (U.S.) Business Overview
9.1.5 Abbott (U.S.) Influenza Vaccination SWOT Analysis
9.1.6 Abbott (U.S.) Recent Developments
9.2 AstraZeneca (Europe)
9.2.1 AstraZeneca (Europe) Influenza Vaccination Basic Information
9.2.2 AstraZeneca (Europe) Influenza Vaccination Product Overview
9.2.3 AstraZeneca (Europe) Influenza Vaccination Product Market Performance
9.2.4 AstraZeneca (Europe) Business Overview
9.2.5 AstraZeneca (Europe) Influenza Vaccination SWOT Analysis
9.2.6 AstraZeneca (Europe) Recent Developments
9.3 BioCryst Pharmaceuticals (U.S.)
9.3.1 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Basic Information
9.3.2 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product Overview
9.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product Market Performance
9.3.4 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination SWOT Analysis
9.3.5 BioCryst Pharmaceuticals (U.S.) Business Overview
9.3.6 BioCryst Pharmaceuticals (U.S.) Recent Developments
9.4 Novartis (Europe)
9.4.1 Novartis (Europe) Influenza Vaccination Basic Information
9.4.2 Novartis (Europe) Influenza Vaccination Product Overview
9.4.3 Novartis (Europe) Influenza Vaccination Product Market Performance
9.4.4 Novartis (Europe) Business Overview
9.4.5 Novartis (Europe) Recent Developments
9.5 DAIICHI SANKYO COMPANY (Asia Pacific)
9.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Basic Information
9.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product Overview
9.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product Market Performance
9.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
9.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments
9.6 GlaxoSmithKline (Europe)
9.6.1 GlaxoSmithKline (Europe) Influenza Vaccination Basic Information
9.6.2 GlaxoSmithKline (Europe) Influenza Vaccination Product Overview
9.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Product Market Performance
9.6.4 GlaxoSmithKline (Europe) Business Overview
9.6.5 GlaxoSmithKline (Europe) Recent Developments
9.7 Hualan Biological Engineering (Asia Pacific)
9.7.1 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Basic Information
9.7.2 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product Overview
9.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product Market Performance
9.7.4 Hualan Biological Engineering (Asia Pacific) Business Overview
9.7.5 Hualan Biological Engineering (Asia Pacific) Recent Developments
9.8 Mitsubishi Tanabe Pharma (Asia Pacific)
9.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Basic Information
9.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product Overview
9.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product Market Performance
9.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
9.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments
9.9 F. Hoffmann-La Roche (Europe)
9.9.1 F. Hoffmann-La Roche (Europe) Influenza Vaccination Basic Information
9.9.2 F. Hoffmann-La Roche (Europe) Influenza Vaccination Product Overview
9.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Product Market Performance
9.9.4 F. Hoffmann-La Roche (Europe) Business Overview
9.9.5 F. Hoffmann-La Roche (Europe) Recent Developments
9.10 Sanofi (Europe)
9.10.1 Sanofi (Europe) Influenza Vaccination Basic Information
9.10.2 Sanofi (Europe) Influenza Vaccination Product Overview
9.10.3 Sanofi (Europe) Influenza Vaccination Product Market Performance
9.10.4 Sanofi (Europe) Business Overview
9.10.5 Sanofi (Europe) Recent Developments
10 INFLUENZA VACCINATION MARKET FORECAST BY REGION
10.1 Global Influenza Vaccination Market Size Forecast
10.2 Global Influenza Vaccination Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Influenza Vaccination Market Size Forecast by Country
10.2.3 Asia Pacific Influenza Vaccination Market Size Forecast by Region
10.2.4 South America Influenza Vaccination Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Influenza Vaccination by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Influenza Vaccination Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Influenza Vaccination by Type (2025-2030)
11.1.2 Global Influenza Vaccination Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Influenza Vaccination by Type (2025-2030)
11.2 Global Influenza Vaccination Market Forecast by Application (2025-2030)
11.2.1 Global Influenza Vaccination Sales (Kilotons) Forecast by Application
11.2.2 Global Influenza Vaccination Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Influenza Vaccination
1.2 Key Market Segments
1.2.1 Influenza Vaccination Segment by Type
1.2.2 Influenza Vaccination Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA VACCINATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Vaccination Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Influenza Vaccination Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA VACCINATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Influenza Vaccination Sales by Manufacturers (2019-2024)
3.2 Global Influenza Vaccination Revenue Market Share by Manufacturers (2019-2024)
3.3 Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Vaccination Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Influenza Vaccination Sales Sites, Area Served, Product Type
3.6 Influenza Vaccination Market Competitive Situation and Trends
3.6.1 Influenza Vaccination Market Concentration Rate
3.6.2 Global 5 and 10 Largest Influenza Vaccination Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFLUENZA VACCINATION INDUSTRY CHAIN ANALYSIS
4.1 Influenza Vaccination Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA VACCINATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFLUENZA VACCINATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Vaccination Sales Market Share by Type (2019-2024)
6.3 Global Influenza Vaccination Market Size Market Share by Type (2019-2024)
6.4 Global Influenza Vaccination Price by Type (2019-2024)
7 INFLUENZA VACCINATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Vaccination Market Sales by Application (2019-2024)
7.3 Global Influenza Vaccination Market Size (M USD) by Application (2019-2024)
7.4 Global Influenza Vaccination Sales Growth Rate by Application (2019-2024)
8 INFLUENZA VACCINATION MARKET SEGMENTATION BY REGION
8.1 Global Influenza Vaccination Sales by Region
8.1.1 Global Influenza Vaccination Sales by Region
8.1.2 Global Influenza Vaccination Sales Market Share by Region
8.2 North America
8.2.1 North America Influenza Vaccination Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Influenza Vaccination Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Influenza Vaccination Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Influenza Vaccination Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Influenza Vaccination Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbott (U.S.)
9.1.1 Abbott (U.S.) Influenza Vaccination Basic Information
9.1.2 Abbott (U.S.) Influenza Vaccination Product Overview
9.1.3 Abbott (U.S.) Influenza Vaccination Product Market Performance
9.1.4 Abbott (U.S.) Business Overview
9.1.5 Abbott (U.S.) Influenza Vaccination SWOT Analysis
9.1.6 Abbott (U.S.) Recent Developments
9.2 AstraZeneca (Europe)
9.2.1 AstraZeneca (Europe) Influenza Vaccination Basic Information
9.2.2 AstraZeneca (Europe) Influenza Vaccination Product Overview
9.2.3 AstraZeneca (Europe) Influenza Vaccination Product Market Performance
9.2.4 AstraZeneca (Europe) Business Overview
9.2.5 AstraZeneca (Europe) Influenza Vaccination SWOT Analysis
9.2.6 AstraZeneca (Europe) Recent Developments
9.3 BioCryst Pharmaceuticals (U.S.)
9.3.1 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Basic Information
9.3.2 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product Overview
9.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product Market Performance
9.3.4 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination SWOT Analysis
9.3.5 BioCryst Pharmaceuticals (U.S.) Business Overview
9.3.6 BioCryst Pharmaceuticals (U.S.) Recent Developments
9.4 Novartis (Europe)
9.4.1 Novartis (Europe) Influenza Vaccination Basic Information
9.4.2 Novartis (Europe) Influenza Vaccination Product Overview
9.4.3 Novartis (Europe) Influenza Vaccination Product Market Performance
9.4.4 Novartis (Europe) Business Overview
9.4.5 Novartis (Europe) Recent Developments
9.5 DAIICHI SANKYO COMPANY (Asia Pacific)
9.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Basic Information
9.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product Overview
9.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product Market Performance
9.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
9.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments
9.6 GlaxoSmithKline (Europe)
9.6.1 GlaxoSmithKline (Europe) Influenza Vaccination Basic Information
9.6.2 GlaxoSmithKline (Europe) Influenza Vaccination Product Overview
9.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Product Market Performance
9.6.4 GlaxoSmithKline (Europe) Business Overview
9.6.5 GlaxoSmithKline (Europe) Recent Developments
9.7 Hualan Biological Engineering (Asia Pacific)
9.7.1 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Basic Information
9.7.2 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product Overview
9.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product Market Performance
9.7.4 Hualan Biological Engineering (Asia Pacific) Business Overview
9.7.5 Hualan Biological Engineering (Asia Pacific) Recent Developments
9.8 Mitsubishi Tanabe Pharma (Asia Pacific)
9.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Basic Information
9.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product Overview
9.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product Market Performance
9.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
9.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments
9.9 F. Hoffmann-La Roche (Europe)
9.9.1 F. Hoffmann-La Roche (Europe) Influenza Vaccination Basic Information
9.9.2 F. Hoffmann-La Roche (Europe) Influenza Vaccination Product Overview
9.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Product Market Performance
9.9.4 F. Hoffmann-La Roche (Europe) Business Overview
9.9.5 F. Hoffmann-La Roche (Europe) Recent Developments
9.10 Sanofi (Europe)
9.10.1 Sanofi (Europe) Influenza Vaccination Basic Information
9.10.2 Sanofi (Europe) Influenza Vaccination Product Overview
9.10.3 Sanofi (Europe) Influenza Vaccination Product Market Performance
9.10.4 Sanofi (Europe) Business Overview
9.10.5 Sanofi (Europe) Recent Developments
10 INFLUENZA VACCINATION MARKET FORECAST BY REGION
10.1 Global Influenza Vaccination Market Size Forecast
10.2 Global Influenza Vaccination Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Influenza Vaccination Market Size Forecast by Country
10.2.3 Asia Pacific Influenza Vaccination Market Size Forecast by Region
10.2.4 South America Influenza Vaccination Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Influenza Vaccination by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Influenza Vaccination Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Influenza Vaccination by Type (2025-2030)
11.1.2 Global Influenza Vaccination Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Influenza Vaccination by Type (2025-2030)
11.2 Global Influenza Vaccination Market Forecast by Application (2025-2030)
11.2.1 Global Influenza Vaccination Sales (Kilotons) Forecast by Application
11.2.2 Global Influenza Vaccination Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Vaccination Market Size Comparison by Region (M USD)
Table 5. Global Influenza Vaccination Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Influenza Vaccination Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Influenza Vaccination Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Influenza Vaccination Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2022)
Table 10. Global Market Influenza Vaccination Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Influenza Vaccination Sales Sites and Area Served
Table 12. Manufacturers Influenza Vaccination Product Type
Table 13. Global Influenza Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Influenza Vaccination
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Vaccination Market Challenges
Table 22. Global Influenza Vaccination Sales by Type (Kilotons)
Table 23. Global Influenza Vaccination Market Size by Type (M USD)
Table 24. Global Influenza Vaccination Sales (Kilotons) by Type (2019-2024)
Table 25. Global Influenza Vaccination Sales Market Share by Type (2019-2024)
Table 26. Global Influenza Vaccination Market Size (M USD) by Type (2019-2024)
Table 27. Global Influenza Vaccination Market Size Share by Type (2019-2024)
Table 28. Global Influenza Vaccination Price (USD/Ton) by Type (2019-2024)
Table 29. Global Influenza Vaccination Sales (Kilotons) by Application
Table 30. Global Influenza Vaccination Market Size by Application
Table 31. Global Influenza Vaccination Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Influenza Vaccination Sales Market Share by Application (2019-2024)
Table 33. Global Influenza Vaccination Sales by Application (2019-2024) & (M USD)
Table 34. Global Influenza Vaccination Market Share by Application (2019-2024)
Table 35. Global Influenza Vaccination Sales Growth Rate by Application (2019-2024)
Table 36. Global Influenza Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Influenza Vaccination Sales Market Share by Region (2019-2024)
Table 38. North America Influenza Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Influenza Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Influenza Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Influenza Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Influenza Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 43. Abbott (U.S.) Influenza Vaccination Basic Information
Table 44. Abbott (U.S.) Influenza Vaccination Product Overview
Table 45. Abbott (U.S.) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Abbott (U.S.) Business Overview
Table 47. Abbott (U.S.) Influenza Vaccination SWOT Analysis
Table 48. Abbott (U.S.) Recent Developments
Table 49. AstraZeneca (Europe) Influenza Vaccination Basic Information
Table 50. AstraZeneca (Europe) Influenza Vaccination Product Overview
Table 51. AstraZeneca (Europe) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AstraZeneca (Europe) Business Overview
Table 53. AstraZeneca (Europe) Influenza Vaccination SWOT Analysis
Table 54. AstraZeneca (Europe) Recent Developments
Table 55. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Basic Information
Table 56. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product Overview
Table 57. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination SWOT Analysis
Table 59. BioCryst Pharmaceuticals (U.S.) Business Overview
Table 60. BioCryst Pharmaceuticals (U.S.) Recent Developments
Table 61. Novartis (Europe) Influenza Vaccination Basic Information
Table 62. Novartis (Europe) Influenza Vaccination Product Overview
Table 63. Novartis (Europe) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Novartis (Europe) Business Overview
Table 65. Novartis (Europe) Recent Developments
Table 66. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Basic Information
Table 67. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product Overview
Table 68. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
Table 70. DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments
Table 71. GlaxoSmithKline (Europe) Influenza Vaccination Basic Information
Table 72. GlaxoSmithKline (Europe) Influenza Vaccination Product Overview
Table 73. GlaxoSmithKline (Europe) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline (Europe) Business Overview
Table 75. GlaxoSmithKline (Europe) Recent Developments
Table 76. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Basic Information
Table 77. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product Overview
Table 78. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Hualan Biological Engineering (Asia Pacific) Business Overview
Table 80. Hualan Biological Engineering (Asia Pacific) Recent Developments
Table 81. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Basic Information
Table 82. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product Overview
Table 83. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
Table 85. Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments
Table 86. F. Hoffmann-La Roche (Europe) Influenza Vaccination Basic Information
Table 87. F. Hoffmann-La Roche (Europe) Influenza Vaccination Product Overview
Table 88. F. Hoffmann-La Roche (Europe) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. F. Hoffmann-La Roche (Europe) Business Overview
Table 90. F. Hoffmann-La Roche (Europe) Recent Developments
Table 91. Sanofi (Europe) Influenza Vaccination Basic Information
Table 92. Sanofi (Europe) Influenza Vaccination Product Overview
Table 93. Sanofi (Europe) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Sanofi (Europe) Business Overview
Table 95. Sanofi (Europe) Recent Developments
Table 96. Global Influenza Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Influenza Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Influenza Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Influenza Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Influenza Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Influenza Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Influenza Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Influenza Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Influenza Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Influenza Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Influenza Vaccination Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Influenza Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Influenza Vaccination Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Influenza Vaccination Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Influenza Vaccination Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Influenza Vaccination Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Influenza Vaccination Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Vaccination Market Size Comparison by Region (M USD)
Table 5. Global Influenza Vaccination Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Influenza Vaccination Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Influenza Vaccination Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Influenza Vaccination Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccination as of 2022)
Table 10. Global Market Influenza Vaccination Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Influenza Vaccination Sales Sites and Area Served
Table 12. Manufacturers Influenza Vaccination Product Type
Table 13. Global Influenza Vaccination Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Influenza Vaccination
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Vaccination Market Challenges
Table 22. Global Influenza Vaccination Sales by Type (Kilotons)
Table 23. Global Influenza Vaccination Market Size by Type (M USD)
Table 24. Global Influenza Vaccination Sales (Kilotons) by Type (2019-2024)
Table 25. Global Influenza Vaccination Sales Market Share by Type (2019-2024)
Table 26. Global Influenza Vaccination Market Size (M USD) by Type (2019-2024)
Table 27. Global Influenza Vaccination Market Size Share by Type (2019-2024)
Table 28. Global Influenza Vaccination Price (USD/Ton) by Type (2019-2024)
Table 29. Global Influenza Vaccination Sales (Kilotons) by Application
Table 30. Global Influenza Vaccination Market Size by Application
Table 31. Global Influenza Vaccination Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Influenza Vaccination Sales Market Share by Application (2019-2024)
Table 33. Global Influenza Vaccination Sales by Application (2019-2024) & (M USD)
Table 34. Global Influenza Vaccination Market Share by Application (2019-2024)
Table 35. Global Influenza Vaccination Sales Growth Rate by Application (2019-2024)
Table 36. Global Influenza Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Influenza Vaccination Sales Market Share by Region (2019-2024)
Table 38. North America Influenza Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Influenza Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Influenza Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Influenza Vaccination Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Influenza Vaccination Sales by Region (2019-2024) & (Kilotons)
Table 43. Abbott (U.S.) Influenza Vaccination Basic Information
Table 44. Abbott (U.S.) Influenza Vaccination Product Overview
Table 45. Abbott (U.S.) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Abbott (U.S.) Business Overview
Table 47. Abbott (U.S.) Influenza Vaccination SWOT Analysis
Table 48. Abbott (U.S.) Recent Developments
Table 49. AstraZeneca (Europe) Influenza Vaccination Basic Information
Table 50. AstraZeneca (Europe) Influenza Vaccination Product Overview
Table 51. AstraZeneca (Europe) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AstraZeneca (Europe) Business Overview
Table 53. AstraZeneca (Europe) Influenza Vaccination SWOT Analysis
Table 54. AstraZeneca (Europe) Recent Developments
Table 55. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Basic Information
Table 56. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product Overview
Table 57. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination SWOT Analysis
Table 59. BioCryst Pharmaceuticals (U.S.) Business Overview
Table 60. BioCryst Pharmaceuticals (U.S.) Recent Developments
Table 61. Novartis (Europe) Influenza Vaccination Basic Information
Table 62. Novartis (Europe) Influenza Vaccination Product Overview
Table 63. Novartis (Europe) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Novartis (Europe) Business Overview
Table 65. Novartis (Europe) Recent Developments
Table 66. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Basic Information
Table 67. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product Overview
Table 68. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. DAIICHI SANKYO COMPANY (Asia Pacific) Business Overview
Table 70. DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments
Table 71. GlaxoSmithKline (Europe) Influenza Vaccination Basic Information
Table 72. GlaxoSmithKline (Europe) Influenza Vaccination Product Overview
Table 73. GlaxoSmithKline (Europe) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. GlaxoSmithKline (Europe) Business Overview
Table 75. GlaxoSmithKline (Europe) Recent Developments
Table 76. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Basic Information
Table 77. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product Overview
Table 78. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Hualan Biological Engineering (Asia Pacific) Business Overview
Table 80. Hualan Biological Engineering (Asia Pacific) Recent Developments
Table 81. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Basic Information
Table 82. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product Overview
Table 83. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Mitsubishi Tanabe Pharma (Asia Pacific) Business Overview
Table 85. Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments
Table 86. F. Hoffmann-La Roche (Europe) Influenza Vaccination Basic Information
Table 87. F. Hoffmann-La Roche (Europe) Influenza Vaccination Product Overview
Table 88. F. Hoffmann-La Roche (Europe) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. F. Hoffmann-La Roche (Europe) Business Overview
Table 90. F. Hoffmann-La Roche (Europe) Recent Developments
Table 91. Sanofi (Europe) Influenza Vaccination Basic Information
Table 92. Sanofi (Europe) Influenza Vaccination Product Overview
Table 93. Sanofi (Europe) Influenza Vaccination Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Sanofi (Europe) Business Overview
Table 95. Sanofi (Europe) Recent Developments
Table 96. Global Influenza Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Influenza Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Influenza Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Influenza Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Influenza Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Influenza Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Influenza Vaccination Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Influenza Vaccination Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Influenza Vaccination Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Influenza Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Influenza Vaccination Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Influenza Vaccination Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Influenza Vaccination Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Influenza Vaccination Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Influenza Vaccination Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Influenza Vaccination Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Influenza Vaccination Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Influenza Vaccination
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Vaccination Market Size (M USD), 2019-2030
Figure 5. Global Influenza Vaccination Market Size (M USD) (2019-2030)
Figure 6. Global Influenza Vaccination Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Vaccination Market Size by Country (M USD)
Figure 11. Influenza Vaccination Sales Share by Manufacturers in 2023
Figure 12. Global Influenza Vaccination Revenue Share by Manufacturers in 2023
Figure 13. Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Influenza Vaccination Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Vaccination Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Influenza Vaccination Market Share by Type
Figure 18. Sales Market Share of Influenza Vaccination by Type (2019-2024)
Figure 19. Sales Market Share of Influenza Vaccination by Type in 2023
Figure 20. Market Size Share of Influenza Vaccination by Type (2019-2024)
Figure 21. Market Size Market Share of Influenza Vaccination by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Influenza Vaccination Market Share by Application
Figure 24. Global Influenza Vaccination Sales Market Share by Application (2019-2024)
Figure 25. Global Influenza Vaccination Sales Market Share by Application in 2023
Figure 26. Global Influenza Vaccination Market Share by Application (2019-2024)
Figure 27. Global Influenza Vaccination Market Share by Application in 2023
Figure 28. Global Influenza Vaccination Sales Growth Rate by Application (2019-2024)
Figure 29. Global Influenza Vaccination Sales Market Share by Region (2019-2024)
Figure 30. North America Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Influenza Vaccination Sales Market Share by Country in 2023
Figure 32. U.S. Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Influenza Vaccination Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Influenza Vaccination Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Influenza Vaccination Sales Market Share by Country in 2023
Figure 37. Germany Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Influenza Vaccination Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Influenza Vaccination Sales Market Share by Region in 2023
Figure 44. China Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Influenza Vaccination Sales and Growth Rate (Kilotons)
Figure 50. South America Influenza Vaccination Sales Market Share by Country in 2023
Figure 51. Brazil Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Influenza Vaccination Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Influenza Vaccination Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Influenza Vaccination Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Influenza Vaccination Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Influenza Vaccination Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Influenza Vaccination Market Share Forecast by Type (2025-2030)
Figure 65. Global Influenza Vaccination Sales Forecast by Application (2025-2030)
Figure 66. Global Influenza Vaccination Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Influenza Vaccination
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Vaccination Market Size (M USD), 2019-2030
Figure 5. Global Influenza Vaccination Market Size (M USD) (2019-2030)
Figure 6. Global Influenza Vaccination Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Vaccination Market Size by Country (M USD)
Figure 11. Influenza Vaccination Sales Share by Manufacturers in 2023
Figure 12. Global Influenza Vaccination Revenue Share by Manufacturers in 2023
Figure 13. Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Influenza Vaccination Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Vaccination Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Influenza Vaccination Market Share by Type
Figure 18. Sales Market Share of Influenza Vaccination by Type (2019-2024)
Figure 19. Sales Market Share of Influenza Vaccination by Type in 2023
Figure 20. Market Size Share of Influenza Vaccination by Type (2019-2024)
Figure 21. Market Size Market Share of Influenza Vaccination by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Influenza Vaccination Market Share by Application
Figure 24. Global Influenza Vaccination Sales Market Share by Application (2019-2024)
Figure 25. Global Influenza Vaccination Sales Market Share by Application in 2023
Figure 26. Global Influenza Vaccination Market Share by Application (2019-2024)
Figure 27. Global Influenza Vaccination Market Share by Application in 2023
Figure 28. Global Influenza Vaccination Sales Growth Rate by Application (2019-2024)
Figure 29. Global Influenza Vaccination Sales Market Share by Region (2019-2024)
Figure 30. North America Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Influenza Vaccination Sales Market Share by Country in 2023
Figure 32. U.S. Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Influenza Vaccination Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Influenza Vaccination Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Influenza Vaccination Sales Market Share by Country in 2023
Figure 37. Germany Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Influenza Vaccination Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Influenza Vaccination Sales Market Share by Region in 2023
Figure 44. China Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Influenza Vaccination Sales and Growth Rate (Kilotons)
Figure 50. South America Influenza Vaccination Sales Market Share by Country in 2023
Figure 51. Brazil Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Influenza Vaccination Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Influenza Vaccination Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Influenza Vaccination Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Influenza Vaccination Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Influenza Vaccination Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Influenza Vaccination Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Influenza Vaccination Market Share Forecast by Type (2025-2030)
Figure 65. Global Influenza Vaccination Sales Forecast by Application (2025-2030)
Figure 66. Global Influenza Vaccination Market Share Forecast by Application (2025-2030)
